The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Infertility Services-Global Market Insights and Sales Trends 2024
Synopsis
In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.
The global Infertility Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Infertility Services in various end use industries. The expanding demands from the Male and Female, are propelling Infertility Services market. Assisted Reproductive Technology (ART), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Infertility Drug Services segment is estimated at % CAGR for the next seven-year period.
Some infertility Services include Assisted Reproductive Technology (ART), Infertility drug Services, Artificial Insemination and Fertility Surgeries.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infertility Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infertility Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infertility Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infertility Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infertility Services covered in this report include CARE facility, CooperSurgical, Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, AbbVie, Apricus Biosciences and AstraZeneca, etc.
The global Infertility Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife
AbbVie
Apricus Biosciences
AstraZeneca
Auxogyn
Eli Lilly
EMD Serono
IKS International
InVitro Care
INVO Bioscience
Irvine Scientific
LifeGlobal
MedITEX
NMC Health
OB GYN Associates
OvaScience
Pantec Biosolutions
Reproductive Medicine Associates of New Jersey
The Sims Clinic
TriHealth
Virtus Health
Xytex Cryo International
Global Infertility Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infertility Services market, Segment by Type:
Assisted Reproductive Technology (ART)
Infertility Drug Services
Others
Global Infertility Services market, by Application
Male
Female
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infertility Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.
The global Infertility Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Infertility Services in various end use industries. The expanding demands from the Male and Female, are propelling Infertility Services market. Assisted Reproductive Technology (ART), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Infertility Drug Services segment is estimated at % CAGR for the next seven-year period.
Some infertility Services include Assisted Reproductive Technology (ART), Infertility drug Services, Artificial Insemination and Fertility Surgeries.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infertility Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infertility Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infertility Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infertility Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infertility Services covered in this report include CARE facility, CooperSurgical, Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, AbbVie, Apricus Biosciences and AstraZeneca, etc.
The global Infertility Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife
AbbVie
Apricus Biosciences
AstraZeneca
Auxogyn
Eli Lilly
EMD Serono
IKS International
InVitro Care
INVO Bioscience
Irvine Scientific
LifeGlobal
MedITEX
NMC Health
OB GYN Associates
OvaScience
Pantec Biosolutions
Reproductive Medicine Associates of New Jersey
The Sims Clinic
TriHealth
Virtus Health
Xytex Cryo International
Global Infertility Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infertility Services market, Segment by Type:
Assisted Reproductive Technology (ART)
Infertility Drug Services
Others
Global Infertility Services market, by Application
Male
Female
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infertility Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Infertility Services
1.1 Infertility Services Market Overview
1.1.1 Infertility Services Product Scope
1.1.2 Infertility Services Market Status and Outlook
1.2 Global Infertility Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infertility Services Market Size by Region (2018-2029)
1.4 Global Infertility Services Historic Market Size by Region (2018-2023)
1.5 Global Infertility Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infertility Services Market Size (2018-2029)
1.6.1 North America Infertility Services Market Size (2018-2029)
1.6.2 Europe Infertility Services Market Size (2018-2029)
1.6.3 Asia-Pacific Infertility Services Market Size (2018-2029)
1.6.4 Latin America Infertility Services Market Size (2018-2029)
1.6.5 Middle East & Africa Infertility Services Market Size (2018-2029)
2 Infertility Services Market by Type
2.1 Introduction
2.1.1 Assisted Reproductive Technology (ART)
2.1.2 Infertility Drug Services
2.1.3 Others
2.2 Global Infertility Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infertility Services Historic Market Size by Type (2018-2023)
2.2.2 Global Infertility Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infertility Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infertility Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infertility Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infertility Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infertility Services Revenue Breakdown by Type (2018-2029)
3 Infertility Services Market Overview by Application
3.1 Introduction
3.1.1 Male
3.1.2 Female
3.2 Global Infertility Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infertility Services Historic Market Size by Application (2018-2023)
3.2.2 Global Infertility Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infertility Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infertility Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infertility Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infertility Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infertility Services Revenue Breakdown by Application (2018-2029)
4 Infertility Services Competition Analysis by Players
4.1 Global Infertility Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infertility Services as of 2022)
4.3 Date of Key Players Enter into Infertility Services Market
4.4 Global Top Players Infertility Services Headquarters and Area Served
4.5 Key Players Infertility Services Product Solution and Service
4.6 Competitive Status
4.6.1 Infertility Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 CARE facility
5.1.1 CARE facility Profile
5.1.2 CARE facility Main Business
5.1.3 CARE facility Infertility Services Products, Services and Solutions
5.1.4 CARE facility Infertility Services Revenue (US$ Million) & (2018-2023)
5.1.5 CARE facility Recent Developments
5.2 CooperSurgical
5.2.1 CooperSurgical Profile
5.2.2 CooperSurgical Main Business
5.2.3 CooperSurgical Infertility Services Products, Services and Solutions
5.2.4 CooperSurgical Infertility Services Revenue (US$ Million) & (2018-2023)
5.2.5 CooperSurgical Recent Developments
5.3 Ferring Pharmaceuticals
5.3.1 Ferring Pharmaceuticals Profile
5.3.2 Ferring Pharmaceuticals Main Business
5.3.3 Ferring Pharmaceuticals Infertility Services Products, Services and Solutions
5.3.4 Ferring Pharmaceuticals Infertility Services Revenue (US$ Million) & (2018-2023)
5.3.5 Monash IVF Recent Developments
5.4 Monash IVF
5.4.1 Monash IVF Profile
5.4.2 Monash IVF Main Business
5.4.3 Monash IVF Infertility Services Products, Services and Solutions
5.4.4 Monash IVF Infertility Services Revenue (US$ Million) & (2018-2023)
5.4.5 Monash IVF Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Infertility Services Products, Services and Solutions
5.5.4 Merck Infertility Services Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Recent Developments
5.6 Vitrolife
5.6.1 Vitrolife Profile
5.6.2 Vitrolife Main Business
5.6.3 Vitrolife Infertility Services Products, Services and Solutions
5.6.4 Vitrolife Infertility Services Revenue (US$ Million) & (2018-2023)
5.6.5 Vitrolife Recent Developments
5.7 AbbVie
5.7.1 AbbVie Profile
5.7.2 AbbVie Main Business
5.7.3 AbbVie Infertility Services Products, Services and Solutions
5.7.4 AbbVie Infertility Services Revenue (US$ Million) & (2018-2023)
5.7.5 AbbVie Recent Developments
5.8 Apricus Biosciences
5.8.1 Apricus Biosciences Profile
5.8.2 Apricus Biosciences Main Business
5.8.3 Apricus Biosciences Infertility Services Products, Services and Solutions
5.8.4 Apricus Biosciences Infertility Services Revenue (US$ Million) & (2018-2023)
5.8.5 Apricus Biosciences Recent Developments
5.9 AstraZeneca
5.9.1 AstraZeneca Profile
5.9.2 AstraZeneca Main Business
5.9.3 AstraZeneca Infertility Services Products, Services and Solutions
5.9.4 AstraZeneca Infertility Services Revenue (US$ Million) & (2018-2023)
5.9.5 AstraZeneca Recent Developments
5.10 Auxogyn
5.10.1 Auxogyn Profile
5.10.2 Auxogyn Main Business
5.10.3 Auxogyn Infertility Services Products, Services and Solutions
5.10.4 Auxogyn Infertility Services Revenue (US$ Million) & (2018-2023)
5.10.5 Auxogyn Recent Developments
5.11 Eli Lilly
5.11.1 Eli Lilly Profile
5.11.2 Eli Lilly Main Business
5.11.3 Eli Lilly Infertility Services Products, Services and Solutions
5.11.4 Eli Lilly Infertility Services Revenue (US$ Million) & (2018-2023)
5.11.5 Eli Lilly Recent Developments
5.12 EMD Serono
5.12.1 EMD Serono Profile
5.12.2 EMD Serono Main Business
5.12.3 EMD Serono Infertility Services Products, Services and Solutions
5.12.4 EMD Serono Infertility Services Revenue (US$ Million) & (2018-2023)
5.12.5 EMD Serono Recent Developments
5.13 IKS International
5.13.1 IKS International Profile
5.13.2 IKS International Main Business
5.13.3 IKS International Infertility Services Products, Services and Solutions
5.13.4 IKS International Infertility Services Revenue (US$ Million) & (2018-2023)
5.13.5 IKS International Recent Developments
5.14 InVitro Care
5.14.1 InVitro Care Profile
5.14.2 InVitro Care Main Business
5.14.3 InVitro Care Infertility Services Products, Services and Solutions
5.14.4 InVitro Care Infertility Services Revenue (US$ Million) & (2018-2023)
5.14.5 InVitro Care Recent Developments
5.15 INVO Bioscience
5.15.1 INVO Bioscience Profile
5.15.2 INVO Bioscience Main Business
5.15.3 INVO Bioscience Infertility Services Products, Services and Solutions
5.15.4 INVO Bioscience Infertility Services Revenue (US$ Million) & (2018-2023)
5.15.5 INVO Bioscience Recent Developments
5.16 Irvine Scientific
5.16.1 Irvine Scientific Profile
5.16.2 Irvine Scientific Main Business
5.16.3 Irvine Scientific Infertility Services Products, Services and Solutions
5.16.4 Irvine Scientific Infertility Services Revenue (US$ Million) & (2018-2023)
5.16.5 Irvine Scientific Recent Developments
5.17 LifeGlobal
5.17.1 LifeGlobal Profile
5.17.2 LifeGlobal Main Business
5.17.3 LifeGlobal Infertility Services Products, Services and Solutions
5.17.4 LifeGlobal Infertility Services Revenue (US$ Million) & (2018-2023)
5.17.5 LifeGlobal Recent Developments
5.18 MedITEX
5.18.1 MedITEX Profile
5.18.2 MedITEX Main Business
5.18.3 MedITEX Infertility Services Products, Services and Solutions
5.18.4 MedITEX Infertility Services Revenue (US$ Million) & (2018-2023)
5.18.5 MedITEX Recent Developments
5.19 NMC Health
5.19.1 NMC Health Profile
5.19.2 NMC Health Main Business
5.19.3 NMC Health Infertility Services Products, Services and Solutions
5.19.4 NMC Health Infertility Services Revenue (US$ Million) & (2018-2023)
5.19.5 NMC Health Recent Developments
5.20 OB GYN Associates
5.20.1 OB GYN Associates Profile
5.20.2 OB GYN Associates Main Business
5.20.3 OB GYN Associates Infertility Services Products, Services and Solutions
5.20.4 OB GYN Associates Infertility Services Revenue (US$ Million) & (2018-2023)
5.20.5 OB GYN Associates Recent Developments
5.21 OvaScience
5.21.1 OvaScience Profile
5.21.2 OvaScience Main Business
5.21.3 OvaScience Infertility Services Products, Services and Solutions
5.21.4 OvaScience Infertility Services Revenue (US$ Million) & (2018-2023)
5.21.5 OvaScience Recent Developments
5.22 Pantec Biosolutions
5.22.1 Pantec Biosolutions Profile
5.22.2 Pantec Biosolutions Main Business
5.22.3 Pantec Biosolutions Infertility Services Products, Services and Solutions
5.22.4 Pantec Biosolutions Infertility Services Revenue (US$ Million) & (2018-2023)
5.22.5 Pantec Biosolutions Recent Developments
5.23 Reproductive Medicine Associates of New Jersey
5.23.1 Reproductive Medicine Associates of New Jersey Profile
5.23.2 Reproductive Medicine Associates of New Jersey Main Business
5.23.3 Reproductive Medicine Associates of New Jersey Infertility Services Products, Services and Solutions
5.23.4 Reproductive Medicine Associates of New Jersey Infertility Services Revenue (US$ Million) & (2018-2023)
5.23.5 Reproductive Medicine Associates of New Jersey Recent Developments
5.24 The Sims Clinic
5.24.1 The Sims Clinic Profile
5.24.2 The Sims Clinic Main Business
5.24.3 The Sims Clinic Infertility Services Products, Services and Solutions
5.24.4 The Sims Clinic Infertility Services Revenue (US$ Million) & (2018-2023)
5.24.5 The Sims Clinic Recent Developments
5.25 TriHealth
5.25.1 TriHealth Profile
5.25.2 TriHealth Main Business
5.25.3 TriHealth Infertility Services Products, Services and Solutions
5.25.4 TriHealth Infertility Services Revenue (US$ Million) & (2018-2023)
5.25.5 TriHealth Recent Developments
5.26 Virtus Health
5.26.1 Virtus Health Profile
5.26.2 Virtus Health Main Business
5.26.3 Virtus Health Infertility Services Products, Services and Solutions
5.26.4 Virtus Health Infertility Services Revenue (US$ Million) & (2018-2023)
5.26.5 Virtus Health Recent Developments
5.27 Xytex Cryo International
5.27.1 Xytex Cryo International Profile
5.27.2 Xytex Cryo International Main Business
5.27.3 Xytex Cryo International Infertility Services Products, Services and Solutions
5.27.4 Xytex Cryo International Infertility Services Revenue (US$ Million) & (2018-2023)
5.27.5 Xytex Cryo International Recent Developments
6 North America
6.1 North America Infertility Services Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infertility Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infertility Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infertility Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infertility Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infertility Services Market Dynamics
11.1 Infertility Services Industry Trends
11.2 Infertility Services Market Drivers
11.3 Infertility Services Market Challenges
11.4 Infertility Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
